Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00QKL
|
||||
Former ID |
DIB005883
|
||||
Drug Name |
T2c-003
|
||||
Synonyms |
Bone marrow-derived progenitor cells therapy (intra-arterial infusion, diabetic neuropathy), t2cure
|
||||
Indication | Diabetic neuropathy [ICD9: 250, 250.6, 356.0, 356.8; ICD10:E11.40] | Phase 1/2 | [548845] | ||
Company |
Johann Wolfgang Goethe-Universitat Frankfurt am Main
|
||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Modulator | [543707] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.